[Asia Economy Reporter Lee Gwan-ju] Experts from infectious disease research institutions in Korea, the United States, Singapore, and Denmark will gather in one place to explore future cooperation and ways to strengthen networks.
The National Institute of Infectious Diseases at the Korea Disease Control and Prevention Agency's National Institute of Health announced on the 21st that it will hold the "1st International Symposium of Infectious Disease Research Institutions (IDRIC)" in Jeju on the 22nd and 23rd.
Poster of the 1st International Symposium on Infectious Disease Research Institutions. [Photo by Korea Disease Control and Prevention Agency]
Researchers and officials from the U.S. National Institute of Allergy and Infectious Diseases (NIAID), Singapore's National Centre for Infectious Diseases (NCID), and Denmark's Statens Serum Institut (SSI) will participate in this symposium. In Korea, the Infectious Disease Research Institute, centered on the National Institute of Infectious Diseases, and the Infectious Disease Research Institutions Consortium, which includes 17 national responsible agencies, will attend on site.
At this event, to strengthen response capabilities against new and variant infectious diseases, presentations on international joint research achievements with leading institutions will be made, covering rapid vaccine development platform technologies, development of treatments for unresolved infectious diseases (such as tuberculosis, climate change, antibiotic resistance), and future development directions will be discussed through thematic presentation sessions and business meeting groups.
On the first day of the symposium, researchers from the U.S. National Institute of Allergy and Infectious Diseases will be invited to discuss global infectious disease outbreak preparedness, clinical research on novel therapeutics, and research on vaccine adjuvants. On the second day, presentations will be held via video conference and meetings with Singapore's National Centre for Infectious Diseases on topics such as One Health concept antibiotic resistance research and post-COVID-19 sequelae research. Denmark's Statens Serum Institut will cover COVID-19 serosurveillance and immunogenicity research, Danish survey methods, and tuberculosis vaccine development.
Jiyoungmi, Director of the Korea Disease Control and Prevention Agency, said, "Through experiencing COVID-19, close communication and cooperation among national research institutes worldwide have become increasingly important, and it is significant that the National Institute of Infectious Diseases has taken the lead in providing a platform for researchers from each institution to present and exchange the latest research findings." "I hope that future cooperation among research institutions will lay the foundation for a faster and more effective response to future infectious diseases," she added.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
